BMY241101C61000
- 0.01
- 0.000.00%
Bristol-Myers Squibb Newsroom
Nasdaq Hits Record High While Wed Earnings Are Mixed | Wall Street Today
Tuesday Market Falls on Tough Earnings, With AMD and Alphabet Reporting Tonight | Live Stock
Biogen Names Former Bristol-Myers Executive as Medical Chief
Correction to Bristol-Myers Squibb 2024 Guidance Headline on July 26
OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
Slow Day to Start Busy Week | Wall Street Today
Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock
Bristol Myers Shares New Data on COBENFY for Schizophrenia at Psych Congress, Highlighting Long-Term Safety and Patient Satisfaction
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024
Apple, Microsoft, Exxon, and More Stocks to Watch
Heard on the Street: Pfizer's Activist Battle Might Fizzle -- but Its Stock Probably Won't -- WSJ
Earnings Preview: BMY to Report Financial Results Pre-market on October 31
Weekly Buzz: Is Tesla a sign of earnings to come?
Friday Market Falls With Busy Business Ahead | Wall Street Today
Mooer's Stories | How Stock_Drift Navigates Irrational Markets
Friday Market Climbs After Big Earnings, and More to Come | Live Moovin' Stocks
Bristol-Myers Squibb Analyst Ratings
Express News | Bristol-Myers Squibb : Deutsche Bank Raises Target Price to $48 From $45
Citi Downgrades Bristol-Myers Squibb(BMY.US) to Hold Rating, Cuts Target Price to $55
Express News | Bristol-Myers Squibb Co : Citigroup Cuts to Neutral From Buy